MedTrace Logo

Radiologic and Clinical Outcomes of Augmentation in Fragility Intertrochanteric Hip Fracture Treatment

NCT02631824 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2016-09-13

No results posted yet for this study

Summary

Randomized clinical trial to assess if the use of augmentation in the treatment of fragility intertrochanteric hip fractures improves radiologic and clinical outcomes in patients aged 65 years or older 1 year after surgery

Conditions

  • Hip Fractures

Interventions

PROCEDURE

open reduction and internal fixation

Open reduction and internal fixation using an intramedullary nail

DEVICE

TFNA

Trochanteric Femoral Nail Advance

DEVICE

Augmentation (Cement)

Cement placement (3-6ml) through the cephalic blade under fluoroscopic vision. Cement contains 40% zirconuim dioxide, 15% hydroxiapatite, 45% polymethyl methacrylate (PMMA).

Sponsors & Collaborators

  • Fundación Santa Fe de Bogota

    collaborator OTHER

  • Hospital Infantil Universitario de San Jose

    lead OTHER

Principal Investigators

  • Carlos M Olarte, MD · Head of Orthopaedic Department at Hospital Infantil de San José

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2017-11-30
Completion
2017-12-31

Countries

  • Colombia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02631824 on ClinicalTrials.gov